Additionally, hypoalbuminemia common in cancer patients weakens hepatic antioxidant defenses, and the “inflammation-nutrition imbalance” marker NPAR (neutrophil percentage/serum albumin) demonstrates high efficiency in predicting ALI (AUC = 0.89–0.93). This evidence concerns the gene ALB and Hypoalbuminemia.